Locations:

News Releases

Photo of scale wit a tape measure.
November 14, 2026/News Releases

Cleveland Clinic Study Identifies Best Treatment Strategies for Weight Loss After Stopping GLP-1 Drugs

In analysis of more than 20,000 patients, bariatric surgery produced greatest weight loss at 2 years, followed by switching between GLP-1 medications and switching to a non-GLP1 medication

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center
November 13, 2026/News Releases

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

New space expands access to nutrition education, healthy cooking skills and food resources at the Langston Hughes Community Health & Education Center

VeloSano riders
November 12, 2026/News Releases

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

A year of fundraising and generosity accelerates search for a cure through VeloSano, a Cleveland Clinic global fundraising movement to end cancer

Lobby of new Toronto location
November 9, 2026/News Releases

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Larger location expands access to Cleveland Clinic’s global expertise, advanced diagnostics and personalized care

Artist's rendering of gene therapy for high triglycerides.
November 9, 2026/News Releases

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

One-time treatment reduced triglycerides by nearly 65% after 30 days

Artist's illustration of gene editing
November 7, 2026/News Releases

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

ARO-DIMER-PA is a Dual-Target RNA Therapy that targets the liver to lower two key proteins involved in high cholesterol at the same time

Medical illustration of lipoprotein(a) molecule
November 7, 2026/News Releases

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years

Phase 3 HORIZON cardiovascular outcome trial examined the safety and efficacy of pelacarsen in patients with elevated lipoprotein(a) and pre-existing cardiovascular disease

Ali Aminian, M.D., performing bariatric surgery.
November 3, 2026/News Releases

Cleveland Clinic Study Finds Bariatric Surgery Effective for Substantial Weight Loss After GLP-1 Intolerance or Limited Weight Loss

Patients achieved meaningful two-year weight loss after undergoing bariatric surgery

Eric Boose, M.D., uses AI software to document a patient appointment.
October 23, 2026/News Releases

Newsweek Ranks Cleveland Clinic Among World's Best Smart Hospitals

Cleveland Clinic earned Newsweek's new Leader in AI Innovation Distinction

BackPage 1 of 109Next